US' Pfizer has signed a deal with UN-backed Medicines Patent Pool to permit other manufacturers to make and supply its experimental COVID-19 pill for use in 95 countries. This could help in making the treatment available to 53% of the world's population. Medicines Patent Pool's spokesperson estimated that other drugmakers would be able to start producing the pill within months.